Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | AKT1 | P31749 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CDC25A | P30304 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.36 |
| ▸ | PRKCG | P05129 | 1/20 | 0.36 |
| ▸ | PRKCB | P05771 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
| ▸ | PRKCH | P24723 | 1/20 | 0.36 |
| ▸ | PRKCI | P41743 | 1/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.36 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14448032 | 0.91 | FABP3 (0.44) | FABP3SMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL10013704 | 0.88 | SMN1; SMN2 (0.50) | FABP3SMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL5959370 | 0.84 | FABP3 (0.48) | FABP3SMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL2474832 | 0.84 | LAP3 (0.36) | P2RY10GPR34PLA2G2C | |
| SCHEMBL10013706 | 0.83 | SMN1; SMN2 (0.53) | FABP3SMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL14031370 | 0.83 | SMN1; SMN2 (0.53) | FABP3SMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL13996373 | 0.82 | PLA2G2C (0.40) | FABP3P2RY10GPR34PLA2G2C | |
| SCHEMBL25857265 | 0.82 | SMN1; SMN2 (0.46) | FABP3SMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL21973787 | 0.81 | FABP3 (0.42) | FABP3SMN1; SMN2LMNAAKT1ESR1 | |
| SCHEMBL12146347 | 0.81 | PLA2G2C (0.48) | MEN1KMT2AP2RY10GPR34PLA2G2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130190523-A1 | Process for the Preparation of Oxidized Phospholipids | VASCULAR BIOGENICS LTD. (IL) | 2013-07-25 | — | — | US | disclosed |
| US-7655768-B2 | Galactose derivative, drug carrier and medicinal composition | NIPPON SHINYAKU CO., LTD. (JP) | 2010-02-02 | — | — | US | disclosed |
| US-20070244058-A1 | Galactose Derivative, Drug Carrier and Medicinal Composition | NIPPON SHINYAKU CO., LTD. (JP) | 2007-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190523-A1 | Process for the Preparation of Oxidized Phospholipids | PHOSPHO1, SGMS1, SGMS2 | FABP3 923/4885SMN1; SMN2 3561/4885LMNA 2925/4885 |
| US-20070244058-A1 | Galactose Derivative, Drug Carrier and Medicinal Composition | GALK1, GALE, UGGT1 | FABP3 521/4885SMN1; SMN2 2915/4885LMNA 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.